| NAME OF THE PROJECT | : Celecoxib |
| PRODUCT NAME | : Celecoxib Diketone Impurity (CB0) |
| CODE & CAT NO | : LP - 5120-03-004 |
| MOLECULAR FORMULA | : C17H14F3N3O2S |
| MOLECULAR WEIGHT | :381.37 |
| CAS NO | : 170569-99-0 |
| CHEMICAL NAME | :4-[5-(2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide [2-methyl Celecoxib] |
| CAT NO | : LP - 5120-01-001 |
| CAS NO | : 169590-42-5 |
| Mol.F | : C17H14F3N3O2S |
| Mol.Wt. | : 381.37 |
| CAT NO | : LP - 5120-03-001 |
| CAS NO | : 170570-01-1 |
| Mol.F | : C17H14F3N3O2S |
| Mol.Wt. | : 381.37 |
| CAT NO | : LP - 5120-03-001 |
| CAS NO | : 170570-01-1 |
| Mol.F | : C17H14F3N3O2S |
| Mol.Wt. | : 381.37 |
| CAT NO | : LP - 5120-03-007 |
| CAS NO | : 17852-52-7 |
| Mol.F | : C6H10ClN3O2S |
| Mol.Wt. | : 223.68 |
| CAT NO | : LP - 5120-03-003 |
| CAS NO | : 720-94-5 |
| Mol.F | : C11H9F3O2 |
| Mol.Wt. | : 230.18 |
| CAT NO | : LP - 5120-03-004 |
| CAS NO | : 170569-99-0 |
| Mol.F | : C17H14F3N3O2S |
| Mol.Wt. | : 381.37 |
| CAT NO | : LP - 5120-03-005 |
| CAS NO | : 170569-87-6 |
| Mol.F | : C₁₆H₁₂F₃N₃O₂S |
| Mol.Wt. | : 367.35 |
| CAT NO | : LP - 5120-03-006 |
| CAS NO | : 26974-15-2 |
| Mol.F | : C11H9F3N2 |
| Mol.Wt. | : 226.2 |
| CAT NO | : LP - 5120-03-010 |
| CAS NO | : 170569-99-0 |
| Mol.F | : C17H14F3N3O2S |
| Mol.Wt. | : 381.37 |
| CAT NO | : LP - 5120-03-008 |
| CAS NO | : 53764-99-1 |
| Mol.F | : C11H9F3O2 |
| Mol.Wt. | : 230.2 |
| CAT NO | : LP - 5120-03-009 |
| CAS NO | : 163266-02-2 |
| Mol.F | : C₁₁H₉F₃O₂ |
| Mol.Wt. | : 230.18 |
| CAT NO | : LP - 5120-03-011 |
| CAS NO | : 1061214-06-9 |
| Mol.F | : C15H17N3O2S |
| Mol.Wt. | : 303.38 |
CATEGORY : Celecoxib
TOTAL PRODUCTS :12
FILTER BY : API
Lavybens pharma's competitive advanced manufacturing facilities, R & D capabilities, extensive domestic network in Indian Pharma market and International.
Copyrights © Lavybens Pharma All rights Reserved
